Therefore, to clarify whether KDM7A-DGAT2 signaling-induced hepatic steatosis exacerbates or prevents the development of NASH and fibrosis, further studies should be warranted. The gene discussed is DGAT2; the disease is metabolic dysfunction-associated steatohepatitis.